ancer is a major public health problem in the United States, where large racial differences in cancer mortality are evident. According to the American Cancer Society, 1 for the majority of cancer types, AAs have the highest cancer mortality rate and the lowest cancer survival rates of any other racial or ethnic group in the United States.
Insufficient representation of racially and ethnically diverse groups in clinical trials results in inequitable distri bution of the risks and benefits of research participation and reduces generalizability of trial results. 6 AA experience a disproportionate cancer mortality burden and therefore they should be included in cancer clinical trials in numbers that are commensurate with their burden of cancer, because the trials could identify ways to reduce the cancer burden in this population.
impACt of lACK of Knowledge on negAtive perCeptions of CAnCer CliniCAl triAls And reCrUitment
The need to expand the knowledge base of cancer clinical trials among diverse community members is underscored by
Ford and associates, 8 who reviewed 65 studies focusing on recruitment of racially and ethnically diverse participants to cancer clinical trials. Lack of education regarding cancer clinical trials was the most frequently reported barrier to participation. 8 Similarly, Langford and colleagues 5 report that lack of knowledge about clinical trials, and subsequent negative perceptions of them, are formidable barriers to the participation of diverse populations in trials.
Thus, lack of knowledge about trials can lead to negative perceptions of them, which in turn has a negative impact on trial participation. Unfortunately, negative perceptions of cancer clinical trials based on lack of knowledge can negatively impact trial recruitment in the very populations that could most benefit from the scientific knowledge gained through their participation. Fallowfield and co-workers 9 argue that recruitment difficulties often arise from potential participants' lack of understanding of terms such as "randomization." Misperceptions in the randomization process (i.e., for participants with cancer, the minimum level of care received is the best available current treatment rather than placebo) can also lead to suspicion on the part of potential participants about the ethical nature of the research. rationale for the study design
The study design was based on a conceptual framework developed by Swanson and Ward. 11 The framework includes barriers impacting the participation of minority participations in clinical trials. In the framework, sociocultural barriers are defined as fear and mistrust of federally sponsored research, the investigators conducting the research, and/or the institu tions at which the research is conducted. 11 Negative feelings may stem from previous encounters or from hearing reports of others' previous encounters with research studies.
Sociocultural barriers to recruitment of AA into clinical trials also include racial and ethnic discrimination, cultural beliefs regarding illness and disease, mistrust of the health care system, and differences in health beliefs and practices. 11, 12 Figure 1 depicts the conceptual framework. The study outcome was changes in perceptions of cancer clinical trials.
It was hypothesized that the data would show post-program increases in more favorable perceptions of trials compared with pre-program perceptions.
In the Swanson and Ward framework, sociocultural barriers are defined as fear and mistrust of federally sponsored research, the investigators conducting the research, and/or the institutions at which the research is conducted. 11 Negative feelings may stem from previous encounters or from hearing reports of others' previous encounters with research studies.
Sociocultural barriers to recruitment of AA into clinical trials also include racial and ethnic discrimination, cultural An Intervention to Improve Clinical Trial Perceptions beliefs regarding illness and disease, mistrust of the health care system, and differences in health beliefs and practices. 11, 12 In the present study, sociocultural barriers were addressed by employing the following methods. First, the program was conducted in trusted community venues. The investigators also worked with trusted community leaders who endorsed the study and helped to recruit participants to each study session. Using these recruitment methods likely helped to create a sense of trust among study participants, who might not have been familiar with our research program but were familiar with the community members who recruited them.
It is likely that the significant increase in positive perceptions of cancer clinical trials was due in large part to the fact that the program was endorsed by trusted community leaders/ organizers and conducted in trusted community venues.
It is also likely that the sustainability of the program, as demonstrated by the number of sessions that have been conducted by trained participants, is due in large part to the "ownership" of the program by the community partners.
Additionally, most of the investigative team members are AA and thus reflect the racial background of the majority of the participants. Finally, as part of the program, past clinical trial abuses in the Tuskegee Syphilis study were acknowledged but followed by a description of how protections for study As shown in Table 1 , which describes 2007 cancer mortality rates for AA versus EA, the rates are significantly higher for AA. In South Carolina, the cancer mortality rate for AA is 223.1, compared with 183.2 for EA. Table 2 describes the demographic characteristics of the counties where the cancer education program was conducted.
As may be seen, the majority of the counties have median household incomes and per capita incomes below that of the United States or even of South Carolina as a whole. As will be described (see section entitled "Community Engagement Activities Conducted in the Study"), a variety of community engagement strategies were employed to recruit participants in these identified communities.
In South Carolina, racial differences are seen in cancerrelated behaviors. These differences could contribute to the disparities in cancer mortality rates that are shown in Table   1 The cancer education program was designed to be highly interactive and "hands on" rather than merely didactic.
Participants engaged in role play as they practiced sharing the information that they learned with others. They also participated in small group activities to review the information that was presented.
A pretest/posttest design was used. subjects protections that are currently in place as a result of the Tuskegee Syphilis Study. 16 The program also includes graphics to illustrate the processes of random selection and randomization. It was designed to present complex information in an understandable manner using simple, lay language. Members of these organizations were willing to become active and equal partners with the research team to achieve this common goal. The community partners represented public, private, faith-based, social, and fraternal organizations.
Creating a strong coalition of community partners led directly to the benefit of combining the knowledge and experience of each partner in working together to seek solutions for the major health challenges facing their communities.
Role of the Community Partners in Recruiting Participants
for the Program. Partners were placed into two categories:
Sponsoring or participating (Table 3) • Identifying the target population;
• Considering other community organizations to jointly participate in the program;
• Selecting venues for the program;
• Assisting with promoting the program in the community; and
• Assisting with the pre-registration process for the program.
To facilitate the work with sponsoring and participating partners, the research team hired a part-time community Do you think that patients should be asked to take part in medical research?
Suppose that you were asked to take part in a research study comparing two treatments, both of which were suitable for your illness. Would you be prepared to take part in a study comparing different treatments?
Usually, the only scientific way to compare one treatment with another is for the choice between the two to be made randomly, rather like tossing a coin. Would you be prepared to take part in a study where treatment was chosen at random?
If you answered "No" or "Do not know" to question 3, we would now like to ask you a bit more about this. In a randomized study a choice would be made between two treatments, either of which would be suitable for you. Your doctor and experts in the field do not know for sure if one treatment is better than the other, or if they are both the same, that's why they want to do the study. Would knowing that encourage you to take part?
In a random choice study, if the treatment you were receiving did not suit you for any reason you could leave the study. Your doctor would then give you whatever other treatment might be appropriate for you. Would that encourage you to take part?
Before you agreed to enter a random choice study the doctor would tell you all about the two treatments being compared, before you were allocated to one or the other. Would that encourage you to take part?
If you knew all the following things were taken in account, would you change your mind and agree to take part in the study? Both treatments were completely suitable. You could leave the study if the treatment did not suit you. There is plenty of information before the random choice was made. • Educational brochures (on cancer screening guidelines, information on specific cancer types, and cancer prevention);
Community speakers Bureau
• Breast and prostate visual and tactile models to palpate cancerous lumps (these models are borrowed by community members and returned to the cancer center);
• Information on the screening schedule of the cancer center's mobile cancer screening unit; and
• A sign-up sheet to submit questions related to cancer prevention, screening, diagnosis, and treatment (responses to the questions are provided by clinical staff at the cancer center and are then distributed to the people who submitted the questions). The majority of the patients (77.4%) agreed to enroll in a trial.
This outcome was predicted by the ARTQ with 80.4% accuracy based on the patients' ARTQ scores. 18 In the present study, the investigators evaluated not only respondents who switched to more favorable perceptions of randomized trials but also those who switched to more negative perceptions, so all seven items on the ARTQ were administered to all of the participants. Additional survey items assessed general demographic characteristics of participants, including Hispanic ethnicity, race, highest level of education completed, marital status, household income, age, and gender.
statistical methods
The survey data were double-entered into SPSS 16.0
and were compared for verification of data entry. Analyses were done with SPSS 16.0 (SPSS, Inc., Chicago, IL), and R v2.6.1. Chi-square tests were used to compare demographics The comparison of changes in perception from pre-to posttest is shown in Figure 3 . Circles represent point estimates were done to evaluate differences in reporting patterns in AA and EA. These were primarily descriptive, inspecting point estimates and 95% confidence intervals. However, p-values were also estimated using Fisher's exact tests.
resUlts Table 5 shows the demographic characteristics of all partici pants who were present at the time of the pretest (n = 195).
Most were AA (75.4%). Slightly more than 6% had less than a high school education (6.1%), 10.3% had a high school diploma as their terminal degree, 21.0% had taken some college courses, 27.2% were college graduates, and 27.2% had completed postgraduate studies. About half were married or living as married (45.1%), slightly more than half were female (53.3%), and almost half had an annual household income of less than $40,000 (45.6%).
The sites also differed in the percentage of participants with less than a college diploma (Table 6 ). Educational differences were most pronounced in the Denmark, Georgetown, and Ridgeville sites. These three sites included higher percentages of participants with less than a college diploma (62.5%, 60.0%, and 64.0%, respectively). In addition, the Ridgeville site was the only site that included Native American/American Indian participants: 60% of the participants at the Ridgeville site were
Native American. Table 7 shows the number of participants at each site.
As noted, almost 90% of those who pre-registered showed up to participate. Slightly more than half of the study participants were women. It is unclear whether similar responses would have been seen in a sample that had a greater proportion of men.
However, in our previous study focusing on recruitment of AA men to a cancer clinical trial, female spouses or partners were found to serve as "gatekeepers" in terms of access to the male study participants. The prior study also showed that women transmitted health information to the men in their lives. 7, 19 Therefore, in the present study, although efforts were made to include men by publicizing the cancer education sessions in each area with male-dominated organizations such as fraternities, Masonic orders, and ministerial alliances, the investi gators felt confident that the women who participated in the sessions would share the information with their husbands, sons, nephews, and so on.
This study has a number of strengths. First, it incorporated a community-based recruitment strategy. The investigators Census Bureau estimates, only 15.1% of the South Carolina population over the age of 25 has completed their bachelor's degree. 23 In the present study, 27.2% of participants had obtained a college diploma and another 27.2% had completed their postgraduate education. Thus, the participants in this study were more highly educated than the general population of South Carolina.
Changes in knowledge and perceptions are not automatically associated with changes in health behavior.
However, the results of a recent study suggest that educating people allows them to make better health decisions because they process health information more effectively. In another study, Lange 24 
ConClUsions
Providing cancer clinical trials information to predominantly AA populations in South Carolina led to more positive perceptions of cancer clinical trials. Future research studies will incorporate a longer follow-up period to assess whether short-term gains are sustained over time and whether the participants actually enrolled in a trial. Also, in future studies, the program outcomes from the sessions conducted by the trained community members will be evaluated.
